Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Amplification of spatially isolated adenosine pathway by tumor–macrophage interaction induces anti-PD1 resistance in hepatocellular carcinoma
Jia‐Cheng Lu, Pengfei Zhang, Xiaoyong Huang, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 106

Showing 1-25 of 106 citing articles:

Exosome-derived circCCAR1 promotes CD8 + T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma
Zongqiang Hu, Gang Chen, Yingpeng Zhao, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 169
Immune checkpoint inhibitor resistance in hepatocellular carcinoma
Zhijie Wang, Yichuan Wang, Peng Gao, et al.
Cancer Letters (2022) Vol. 555, pp. 216038-216038
Closed Access | Times Cited: 85
Gamma delta T-cell-based immune checkpoint therapy: attractive candidate for antitumor treatment
Zhifei Gao, Yifeng Bai, Anqi Lin, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 73
Emerging Role of Circular RNAs in Hepatocellular Carcinoma Immunotherapy
Tasneem Abaza, Mostafa K. Abd El‐Aziz, Kerolos Ashraf Daniel, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16484-16484
Open Access | Times Cited: 49
Targeting tumor exosomal circular RNA cSERPINE2 suppresses breast cancer progression by modulating MALT1-NF-𝜅B-IL-6 axis of tumor-associated macrophages
Boxuan Zhou, Zhaohong Mo, Guie Lai, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 46
Liquid biopsy for human cancer: cancer screening, monitoring, and treatment
Hao Wang, Yi Zhang, Hao Zhang, et al.
MedComm (2024) Vol. 5, Iss. 6
Open Access | Times Cited: 21
Cancer-derived exosomes as novel biomarkers in metastatic gastrointestinal cancer
Danyang Zhong, Ziyuan Wang, Zhichao Ye, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 19
CircPAK1 promotes the progression of hepatocellular carcinoma via modulation of YAP nucleus localization by interacting with 14-3-3ζ
Xiaopei Hao, Yao Zhang, Xiaoli Shi, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 47
Exosomal circRNAs in cancer: Implications for therapy resistance and biomarkers
Zhengjun Lin, Yuqiao Ji, Jian Zhou, et al.
Cancer Letters (2023) Vol. 566, pp. 216245-216245
Closed Access | Times Cited: 37
Extracellular vesicles remodel tumor environment for cancer immunotherapy
Yue Ming, Shengyun Hu, Haifeng Sun, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 37
CircRNA MBOAT2 promotes intrahepatic cholangiocarcinoma progression and lipid metabolism reprogramming by stabilizing PTBP1 to facilitate FASN mRNA cytoplasmic export
Xiaopeng Yu, Huanjun Tong, Jialu Chen, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 36
Overcoming acquired resistance to cancer immune checkpoint therapy: potential strategies based on molecular mechanisms
Bin Wang, Han Yin, Yuyu Zhang, et al.
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 35
The Clinical Significance of CD73 in Cancer
Niklas Bach, Riekje Winzer, Eva Tolosa, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11759-11759
Open Access | Times Cited: 30
Targeting immune checkpoints on tumor-associated macrophages in tumor immunotherapy
Shumin Xu, Chenyang Wang, Lingge Yang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 29
ALKBH5 prevents hepatocellular carcinoma progression by post-transcriptional inhibition of PAQR4 in an m6A dependent manner
Weijian Wang, Qibo Huang, Zhibin Liao, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 26
Regulation of the tumor immune microenvironment by cancer-derived circular RNAs
Liping Guan, Qian Hao, Fenfen Shi, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 24
Myeloid-like tumor hybrid cells in bone marrow promote progression of prostate cancer bone metastasis
Xinyu Ye, Xin Huang, Xing Fu, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 24
Cancer cell-intrinsic PD-1: Its role in malignant progression and immunotherapy
Muhua Chen, Lei Bie, Ying Jieer
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115514-115514
Open Access | Times Cited: 24
CircRNAs in tumor immunity and immunotherapy: Perspectives from innate and adaptive immunity
Lulu Yu, Qi Xiao, Bing Yu, et al.
Cancer Letters (2023) Vol. 564, pp. 216219-216219
Open Access | Times Cited: 23
Metabolic interplay: tumor macrophages and regulatory T cells
Stefania Vilbois, Yingxi Xu, Ping‐Chih Ho
Trends in cancer (2023) Vol. 10, Iss. 3, pp. 242-255
Closed Access | Times Cited: 23
The role of circular RNAs in regulating resistance to cancer immunotherapy: mechanisms and implications
Yu Ma, Ting Wang, Xudong Zhang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 5
Open Access | Times Cited: 15
Mutual regulation of PD-L1 immunosuppression between tumor-associated macrophages and tumor cells: a critical role for exosomes
Banglu Wang, Daoan Cheng, Danyu Ma, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 9
Regulatory T cells and immune escape in HCC: understanding the tumor microenvironment and advancing CAR-T cell therapy
Guangtan Du, Cunmiao Dou, Peng Sun, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
A comprehensive review of immune checkpoint inhibitors for cancer treatment
Md Aslam Hossain
International Immunopharmacology (2024) Vol. 143, pp. 113365-113365
Closed Access | Times Cited: 8
ATP ion channel-type P2X purinergic receptors as a key regulatory molecule in breast cancer progression
Xiaowei Nie, Teng-Zheng Li, Chao Peng
Pathology - Research and Practice (2025) Vol. 267, pp. 155844-155844
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top